RespireRx Pharmaceuticals Inc (fka RSPI)

[DewDiligence]

Point taken that all companies have abandoned MCI.

The intent of the post cited by Aiming was to focus on COR’s prospects in RD. Although there’s a plausible explanation for each failure and switched indication in COR’s past programs, the series of failures and switched indications makes me more skeptical of the prospects in RD than I otherwise would be.

That COR only recently discovered the RD indication adds to my skepticism.

Some posters on this board have stated that the RD indication is an outright scam. I don’t think that, but I do think the newfound emphasis on RD may be an example of Zebra’s Law. Regards, Dew

p.s. Regrettably, it looks like Wakefield is pitching after all. It’s too bad that baseball managers find it difficult to manage in a way that maximizes their teams’ winning chances.